Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2602 USD | -5.14% | +7.52% | -37.45% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BayMedica
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 22-01-31 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 18-03-12 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 22-05-11 |
Nicole Lemerond
BRD | Director/Board Member | 48 | 22-08-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,056,970 | 5,974,441 ( 98.64 %) | 0 | 98.64 % |
Company contact information
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.comSector
Sales per Business
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.45% | 1.66M | |
+3.89% | 108B | |
+11.03% | 104B | |
+1.28% | 22.33B | |
-12.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.86% | 17.64B | |
+3.57% | 14.05B | |
+36.99% | 12.51B |
- Stock Market
- Equities
- INM Stock
- Company InMed Pharmaceuticals Inc.